Finally, functional assays would be required to definitively address the suppressive activity of DLBCL ncMO for instance using mice models allowing to track the cMO to ncMO transition and the migration to tissue during the lymphoma course will also be valuable. This evidence concerns the gene MOS and diffuse large B-cell lymphoma.